Free delivery Australia-wide

Perimenopause and Menopause. A multi-system transition, not a hormone problem

Oestradiol does not decline in a straight line. It swings, and six systems adapt to the swing: thermoregulation, sleep, the brain, metabolism, bone and the gut. Hormones are the trigger. What you feel is those systems adjusting, and most of them are measurable.

Order a vivaINSIGHT Test
Perimenopause and Menopause. A multi-system transition, not a hormone problem

SHORT ANSWER

Perimenopause is staged from your cycle, not from one blood test, because oestradiol and FSH swing month to month during the transition. Testing has a different job: measuring the metabolic, inflammatory, bone-relevant and gut markers that shift alongside the hormones, and that respond to what you change.

The Three Stages

Reproductive ageing is staged internationally by the STRAW+10 criteria, which use bleeding pattern first and hormones second. Knowing which stage you are in changes what a marker means.[1]

Late reproductive

Cycles still regular, but subtly shorter. Ovarian reserve is falling and FSH is beginning to rise. Symptoms are usually absent or dismissed.

Menopause transition

Cycle length varies by seven days or more, then gaps of 60 days or more appear. This is perimenopause, and it is where symptoms cluster.

Postmenopause

Dated retrospectively, 12 months after the final period. Vasomotor symptoms can persist for years into it, while bone and cardiometabolic risk keep moving.

What is actually happening in your body during perimenopause?

Oestradiol falls eventually, but the years before that are defined by volatility rather than decline. Six systems that had been running on a predictable monthly signal have to adapt to an unpredictable one, and each adapts at its own pace. Tap any system to read the mechanism.

Ovarian signalling: the fluctuation, not the fall

Ovarian signalling: the fluctuation, not the fall

Oestradiol becomes erratic, not simply low, as ovarian signalling grows less reliable.

Thermoregulation and the vasomotor reflex

Thermoregulation and the vasomotor reflex

Hot flushes are a temperature reflex, lasting a median 7.4 years.

Sleep architecture and the 3am waking

Sleep architecture and the 3am waking

Sleep disruption rises through the transition and can reduce insulin sensitivity.

Mood and cognition through the transition

Mood and cognition through the transition

Perimenopause is associated with higher risk of depressive symptoms and cognitive change.

Body composition and metabolic flexibility

Body composition and metabolic flexibility

Fat gain accelerates and muscle declines, even when your weight holds steady.

The gut, and how it handles oestrogen

The gut, and how it handles oestrogen

Your gut microbes influence how much oestrogen is reabsorbed into circulation.

BIOLOGICAL DRIFT

The transition is loud. The drift underneath it is not.

Biological drift is the slow change in cellular biomarkers that collectively result in chronic disease, and the symptoms relating to chronic disease as they develop. These could include, weight gain, brain fog, energy loss etc

Hot flushes announce themselves. Bone density, waist circumference and fasting insulin do not, and they are moving fastest in exactly the same years. A standard panel reads you against a population on one day; drift is what your own physiology does across the decade either side of your final period, and much of it happens inside the normal reference range.

DRIFT TIMELINE

Biological Age40

255075
  • Weight management scoreOptimal

    76 / 100

  • Gut discomfort and bloatingOptimal

    80 / 100

  • Microbiome diversityOptimal

    78 / 100

  • Carbohydrate metabolismOptimal

    85 / 100

  • Inflammation scoreOptimal

    81 / 100

WHAT YOU'D NOTICE

The first change is usually the cycle, not the flush. Periods shorten by a day or two, sleep becomes lighter in the second half of the month, and recovery from a hard week takes longer than it used to.

Illustrative cohort model showing biomarker change relative to chronological age. Not patient data or a reference range. Biological age reflects where an individual's level of biomarker degeneration aligns along this chronological trajectory.

WHAT WE MEASURE

Three layers, one process

There is no single perimenopause test. What vivaINSIGHT adds is the metabolic, inflammatory, gut and lifestyle picture moving alongside them. Open a layer for the full marker list.

The biochemical blood panel

vivaLAB does not collect blood. These markers are ordered by your GP and are worth reading alongside your vivaINSIGHT layers above.

FROM DATA TO PLAN

Results become a sequenced plan, then get re-measured

Markers are scored against optimal ranges rather than the broad "not yet abnormal" reference band, then cross-referenced across layers and read against your reproductive stage. The transition is the window where the same effort buys the most, because bone and body composition are moving fastest in exactly these years.

Menopausal hormone therapy is a prescribing decision for you and your doctor. vivaLAB does not prescribe it, recommend for or against it, or replace that conversation. What testing can do is inform the rest of the picture, before and during whatever you decide.

Baseline

All three layers captured on the same day, cycle-timed where relevant, so the picture is internally consistent.

Interpret

Our algorithms weight the markers furthest from optimal and read them against your stage rather than against your age alone.

Personalise

Nutrition, resistance training, sleep and supplement guidance tied to your markers, highest-leverage change first.

Re-test

Bi-annually, which matters more here than at any other life stage because the underlying signal is still changing.

WHERE IT LEADS

The transition sets the trajectory for the thirty years after it

Symptoms end. The changes in bone, vessels and body composition that happen alongside them do not, and they are the reason midlife is the intervention window rather than the recovery period.

DRIFTING SYSTEMTHERAPEUTIC CATEGORYWHERE IT LEADS IF UNADDRESSED
Bone density and turnoverLongevity · Musculoskeletal healthOsteopenia, osteoporosis, fragility fracture
Vascular function and lipidsCardiovascular healthSubclinical atherosclerosis, hypertension, cardiovascular events
Body composition and insulin sensitivityMetabolic health · Stress and weightType 2 diabetes, metabolic syndrome, sarcopenia
Sleep continuitySleep · Cognitive healthChronic insomnia, worsened insulin sensitivity, daytime cognitive load
Mood and cognitionMental health · Cognitive healthPersistent depressive symptoms, sustained cognitive complaint
Gut barrier and microbial diversityGut health · ImmunityPersistent digestive symptoms, higher inflammatory load

Associations described in published literature. Testing identifies and tracks markers; it does not diagnose, treat, cure or prevent any disease.

STOP GUESSING

If you're not testing, you're guessing.

One at-home collection. Three layers. A plan built on your own numbers, and a re-test in six months to see whether it worked.

Top Picks

Stay informed with our curated selection of the latest studies and expert insights on weight management.

Loading articles…

References

Every numbered claim on this page links to a record in PubMed, the US National Library of Medicine's index of biomedical literature.

  1. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. 2012. PMID 22344196
  2. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine, 2015. PMID 25686030
    Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women (SWAN). Sleep, 2008. PMID 18652093
  3. Sleep trajectories before and after the final menstrual period in the Study of Women's Health Across the Nation. 2017. PMID 28944165
  4. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes, 2010. PMID 20585000
  5. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Archives of General
  6. Psychiatry, 2006. PMID 16585467
  7. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 2006. PMID 16585466
  8. Menopause-associated symptoms and cognitive performance: results from the Study of Women's Health Across the Nation. 2010. PMID 20442205
  9. Perimenopause and cognition. 2011. PMID 21961718
  10. Changes in body composition and weight during the menopause transition. JCI Insight, 2019. PMID 30843880
  11. Gut microbial beta-glucuronidase: a vital regulator in female estrogen metabolism. Gut Microbes, 2023. PMID 37559394
  12. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. 2014. PMID 24944465
  13. The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers. 2002. PMID 11889064
  14. Association of dietary fibre intake and gut microbiota in adults. 2018. PMID 30355393
  15. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). Journal of Bone and Mineral Research, 2012. PMID 21976317
  16. Trajectories of vasomotor symptoms and carotid intima media thickness in the Study of Women's Health Across the Nation. Stroke, 2016. PMID 26578657
  17. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. Journal of the American Heart Association, 2021. PMID 33470142
  18. Hypothyroidism. 2017. PMID 28336049